{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:46:52Z","timestamp":1792169212029,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10047-026-01602-6","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:16Z","timestamp":1792166236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between pre-processing total protein and processing time in drop-type cell-free and concentrated ascites reinfusion therapy"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4149-517X","authenticated-orcid":false,"given":"Kazuha","family":"Sagiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Inahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Chubachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"1602_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/1744-9987.12469","volume":"20","author":"K Kozaki","year":"2016","unstructured":"Kozaki K, IInuma M, Takagi T, Fukuda T, Sanpei T, Terunuma Y, et al. Cell-free and concentrated ascites reinfusion therapy for decompensated liver cirrhosis. Ther Apher Dial. 2016;20:376\u201382. https:\/\/doi.org\/10.1111\/1744-9987.12469.","journal-title":"Ther Apher Dial"},{"key":"1602_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10147-014-0750-y","volume":"20","author":"T Ito","year":"2015","unstructured":"Ito T, Hanafusa N, Iwase S, Noiri E, Nangaku M, Nakagawa K, et al. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites. Int J Clin Oncol. 2015;20:623\u20138. https:\/\/doi.org\/10.1007\/s10147-014-0750-y.","journal-title":"Int J Clin Oncol"},{"key":"1602_CR3","unstructured":"Japanese Society of Gastroenterology, Japan Society of Hepatology. Evidence-based clinical practice guidelines for liver cirrhosis 2020. rev. 3rd ed. Tokyo: Nankodo; 2020. p. 82."},{"key":"1602_CR4","first-page":"154","volume-title":"Guidelines for treatment of ovarian cancer, fallopian tube cancer and primary peritoneal cancer 2020","author":"Japan Society of Gynecologic Oncology","year":"2020","unstructured":"Japan Society of Gynecologic Oncology. Guidelines for treatment of ovarian cancer, fallopian tube cancer and primary peritoneal cancer 2020. Tokyo: Kanehara; 2020. p. 154."},{"key":"1602_CR5","volume-title":"Japanese gastric cancer treatment guidelines for physicians","author":"Japanese Gastric Cancer Association","year":"2021","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines for physicians. 6th ed. Tokyo: Kanehara; 2021.","edition":"6th ed"},{"key":"1602_CR6","first-page":"190","volume-title":"Clinical practice guidelines for peritoneal malignancy 2021","author":"Japanese Society of Peritoneal Metastasis","year":"2021","unstructured":"Japanese Society of Peritoneal Metastasis. Clinical practice guidelines for peritoneal malignancy 2021. Tokyo: Kanehara; 2021. p. 190.","edition":"2nd ed"},{"key":"1602_CR7","first-page":"94","volume-title":"Clinical guidelines for gastrointestinal symptoms in cancer patients","author":"Guideline oversight committee of the Japanese Society for Palliative Medicine","year":"2017","unstructured":"Guideline oversight committee of the Japanese Society for Palliative Medicine. Clinical guidelines for gastrointestinal symptoms in cancer patients. 2017 ed. Tokyo: Kanehara; 2017. p. 94.","edition":"2017 ed"},{"key":"1602_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdl499","volume":"18","author":"AA Ayantunde","year":"2007","unstructured":"Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18:945\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdl499.","journal-title":"Ann Oncol"},{"key":"1602_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/aor.12933","volume":"41","author":"Y Yamada","year":"2017","unstructured":"Yamada Y, Harada M, Yamaguchi A, Kobayashi Y, Chino T, Minowa T, et al. Technical performance and clinical effectiveness of drop type with adjustable concentrator-cell free and concentrated ascites reinfusion therapy. Artif Organs. 2017;41:1135\u201344. https:\/\/doi.org\/10.1111\/aor.12933.","journal-title":"Artif Organs"},{"key":"1602_CR10","unstructured":"Asahi Kasei Medical Co., Ltd. Ascites filter AHF-MO: package insert. 10th ed. rev.; 2021."},{"key":"1602_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab161","volume":"8","author":"PA Mackowiak","year":"2021","unstructured":"Mackowiak PA, Chervenak FA, Gr\u00fcnebaum A. Defining fever. Open Forum Infect Dis. 2021;8:ofab161. https:\/\/doi.org\/10.1093\/ofid\/ofab161.","journal-title":"Open Forum Infect Dis"},{"key":"1602_CR12","first-page":"542","volume":"40","author":"S Yamada","year":"2021","unstructured":"Yamada S. Cell-free and concentrated ascites reinfusion therapy (use of drop- and pump-types): ascites filter AHF-MO and ascites concentrator AHF-UP. J Jpn Soc Apher. 2021;40:542\u20138.","journal-title":"J Jpn Soc Apher"},{"key":"1602_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.memsci.2006.08.019","volume":"284","author":"P Le-Clech","year":"2006","unstructured":"Le-Clech P, Chen V, Fane TAG. Fouling in membrane bioreactors used in wastewater treatment. J Membr Sci. 2006;284:17\u201353. https:\/\/doi.org\/10.1016\/j.memsci.2006.08.019.","journal-title":"J Membr Sci"},{"key":"1602_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.memsci.2012.08.008","volume":"423","author":"A Cer\u00f3n-Vivas","year":"2012","unstructured":"Cer\u00f3n-Vivas A, Morgan-Sagastume JM, Noyola A. Intermittent filtration and gas bubbling for fouling reduction in anaerobic membrane bioreactors. J Membr Sci. 2012;423\u2013424:136\u201342. https:\/\/doi.org\/10.1016\/j.memsci.2012.08.008","journal-title":"J Membr Sci"},{"key":"1602_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jwpe.2022.103294","volume":"50","author":"HJ Tanudjaja","year":"2022","unstructured":"Tanudjaja HJ, Anantharaman A, Ng AQQ, Ma Y, Tanis-Kanbur MB, Zydney AL, et al. A review of membrane fouling by proteins in ultrafiltration and microfiltration. J Water Process Eng. 2022;50:103294. https:\/\/doi.org\/10.1016\/j.jwpe.2022.103294.","journal-title":"J Water Process Eng"},{"key":"1602_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"key":"1602_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s10147-018-1371-7","volume":"24","author":"Y Kawata","year":"2019","unstructured":"Kawata Y, Nagasaka K, Matsumoto Y, Oda K, Tanikawa M, Sone K, et al. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites. Int J Clin Oncol. 2019;24:420\u20137. https:\/\/doi.org\/10.1007\/s10147-018-1371-7.","journal-title":"Int J Clin Oncol"},{"key":"1602_CR18","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/jog.14670","volume":"47","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto K, Nagao S, Tsu T, Matsushima T, Ishido Y, Narita M, et al. Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: a prospective cohort study. J Obstet Gynaecol Res. 2021;47:1536\u201343. https:\/\/doi.org\/10.1111\/jog.14670.","journal-title":"J Obstet Gynaecol Res"},{"key":"1602_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177303","volume":"12","author":"N Hanafusa","year":"2017","unstructured":"Hanafusa N, Isoai A, Ishihara T, Inoue T, Ishitani K, Utsugisawa T, et al. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: post-marketing surveillance results. PLoS ONE. 2017;12:e0177303. https:\/\/doi.org\/10.1371\/journal.pone.0177303.","journal-title":"PLoS ONE"},{"key":"1602_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10047-023-01402-2","volume":"27","author":"S Fukunaga","year":"2024","unstructured":"Fukunaga S, Egawa M, Ito T, Tanabe K. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites. J Artif Organs. 2024;27:138\u201345. https:\/\/doi.org\/10.1007\/s10047-023-01402-2.","journal-title":"J Artif Organs"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-026-01602-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-026-01602-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-026-01602-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:18Z","timestamp":1792166238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-026-01602-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1602"],"URL":"https:\/\/doi.org\/10.1007\/s10047-026-01602-6","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"value":"1434-7229","type":"print"},{"value":"1619-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Permission to reproduce material from other sources","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"73"}}